A study on clinico-immunologic response and virologic suppression rates of antiretroviral therapy in the treatment of naïve HIV-positive patients at a tertiary care hospital in Eastern India
Background: The tenofovir–lamivudine–efavirenz regimen was introduced in 2018, and there was a lack of data on the treatment trends in human immunodeficiency virus (HIV) patients in India. Therefore, we initiated this study. Objectives: Our objective was to evaluate the clinical and immunolog...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | MGM Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/mgmj/fulltext/2024/11030/a_study_on_clinico_immunologic_response_and.13.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
The tenofovir–lamivudine–efavirenz regimen was introduced in 2018, and there was a lack of data on the treatment trends in human immunodeficiency virus (HIV) patients in India. Therefore, we initiated this study.
Objectives:
Our objective was to evaluate the clinical and immunological response to antiretroviral therapy (ART), as well as the virological suppression rate in antiretroviral-naïve HIV-positive patients attending the School of Tropical Medicine in Kolkata, West Bengal, India.
Settings and Design:
This longitudinal prospective study was conducted at the School of Tropical Medicine in Kolkata from July 2019 to May 2020.
Materials and Methods:
A total of 106 treatment-naïve HIV-infected patients were recruited and evaluated for clinical, immunological, and virological responses over 6 months following the initiation of ART.
Statistical analysis:
All statistical calculations were performed using R software version 4.0.2. Comparisons between observations were made using the t test, and statistical associations were assessed with Fisher’s exact test.
Results:
All patients were diagnosed with HIV-1 infection, and the mean time to ART initiation was 12.9 days, with a standard deviation of 8.6 days. Among the participants, 75 patients (70.8%) had at least one opportunistic infection (OI), the most common being oral candidiasis, followed by extrapulmonary tuberculosis. Additionally, 59 patients (55.7%) had multiple OIs. The majority of the study population (77.4%) presented with advanced HIV disease. Six patients (5.7%) developed immune reconstitution inflammatory syndrome during the 6-month follow-up period. At baseline, most patients had a CD4 count between 150 and 200 cells/μL, and after 6 months of follow-up, most had a CD4 count above 300 cells/μL. Viral suppression was achieved in 97.1% of patients. Excluding those with poor adherence, the efficacy of the tenofovir–lamivudine–efavirenz regimen in suppressing HIV viral load was 99%.
Conclusion:
This study concludes that there was a significant improvement in clinical and immunological responses, as well as virological suppression, following the initiation of ART in ART-naïve HIV-positive patients at 6 months follow-up. |
|---|---|
| ISSN: | 2347-7962 |